EFM
ADVM

E Fund Management’s Adverum Biotechnologies ADVM Stock Holding History

E Fund Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$100K Buy
+1,014
New +$122K 0.01% 241

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

E Fund Management's ADVM Position: Q1 2021 in Review

E Fund Management opened a new position in Adverum Biotechnologies (ADVM) in Q1 2021: 1,014 shares worth $100K. The stake represents 0.01% of the portfolio and ranks #241 among its holdings.

132 funds tracked by Wall St. Rank hold ADVM as of Q1 2021.

  • E Fund Management held 1,014 shares of Adverum Biotechnologies worth $100K as of Q1 2021.
  • Adverum Biotechnologies was a new E Fund Management position in Q1 2021.
  • Adverum Biotechnologies made up 0.01% of E Fund Management's portfolio in Q1 2021, its #241 holding.
  • 132 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2021.

Based on E Fund Management's 13F filing for Q1 2021, filed 12 May 2021.